| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 46.044 | 90.684 | 126.323 | 180.231 | 162.376 | 265.126 | 325.517 | 412.908 | 514.660 |
| Total Income - EUR | - | 46.044 | 90.684 | 126.345 | 180.278 | 162.471 | 265.253 | 326.995 | 420.941 | 528.090 |
| Total Expenses - EUR | - | 1.358 | 13.359 | 11.800 | 19.223 | 15.315 | 14.398 | 25.612 | 41.816 | 46.443 |
| Gross Profit/Loss - EUR | - | 44.686 | 77.325 | 114.545 | 161.055 | 147.156 | 250.856 | 301.383 | 379.125 | 481.647 |
| Net Profit/Loss - EUR | - | 43.305 | 74.605 | 110.755 | 155.934 | 143.549 | 243.446 | 293.726 | 375.000 | 405.876 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Crisan Uromedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 52 | 0 | 624 | 1.647 | 2.196 | 18.832 | 15.735 | 16.826 | 14.965 |
| Current Assets | - | 44.077 | 75.476 | 111.929 | 155.769 | 142.809 | 226.520 | 387.191 | 459.339 | 567.437 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 45.932 | 26.265 | 46.334 | 10.301 | 18.426 | 218.951 | 42.822 | 29 |
| Cash | - | 44.077 | 29.543 | 85.663 | 109.436 | 132.508 | 208.094 | 168.240 | 416.517 | 567.407 |
| Shareholders Funds | - | 43.349 | 74.657 | 110.807 | 155.984 | 143.599 | 243.495 | 293.775 | 375.048 | 405.924 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 780 | 819 | 1.746 | 1.432 | 1.406 | 1.858 | 109.152 | 101.116 | 176.478 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Crisan Uromedica Srl